World’s Top 20 Companies in Artificial Tears Market 2025: Strategic Overview and Future Trends (2024–2035)

Description

According to a research report published by Spherical Insights & Consulting, The Global Artificial Tears Market Size is projected to Grow from USD 3.02 Billion in 2024 to USD 6.73 Billion by 2035, at a CAGR of 7.56% during the forecast period 2025–2035. Excessive use of digital screens, an aging population, increased pollution, and the need for post-surgery care and preservative-free formulations are the driving factors for this market.

 

Introduction

Artificial tears are lubricating eye drops, gels, or ointments that supplement the natural tear film in the eye to ease dry eye, irritation, or allergy symptoms. The need for eye lubrication is rising due to aging populations, increased use of digital devices, and environmental pollutants. There is a significant shift toward preservative-free, single-dose vials to avoid ocular irritation and increase safety. In 2023, the U.S. FDA recommended the recall of several over-the-counter artificial tears products, including EzriCare and Delsam Pharma brands, due to potential bacterial contamination and quality concerns. This heightened regulatory scrutiny has pushed manufacturers toward stricter manufacturing standards, supporting overall improvements in product quality within the global artificial tears market. Opportunities exist in developing advanced lipid-enhancing formulations that mimic natural tears and superior drug delivery mechanisms. Online pharmacy platforms are becoming crucial distribution channels, offering convenience and broader access for consumers to purchase OTC tear solutions.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Artificial Tears Market.

 

Segment Section

By Type (Cellulose Derived Tears, Glycerin Derived Tears, Oil-based Emulsion Tears, Polythylene Glycol Based Tears, Propylene Glycol Based Tears, Sodium Hyaluronate Based Artificial Tears), Delivery Mode (Eye Drops, Ointments), and Application (Dry Eyes Treatment, Contact Lenses Moisture).

 

Artificial Tears Market Size & Statistics

• The Market Size for Artificial Tears Was Estimated to be worth USD 3.02 Billion in 2024.
• The Market Size is Going to Expand at a CAGR of 7.56% between 2025 and 2035.
• The Global Artificial Tears Market Size is anticipated to reach USD 6.73 Billion by 2035.
• Asia Pacific is estimated to generate the highest demand during the forecast period in The Artificial Tears Market.
• North America is projected to grow the fastest during the forecast period in The Artificial Tears Market

 

Regional Growth and Demand

North America is expected to grow the fastest during the forecast period in the artificial tears market. The increasing prevalence of dry eye syndrome and rising demand for over-the-counter ophthalmic products in the United States and Canada are driving the need for artificial tear formulations. In 2023, the region witnessed significant investments in ophthalmic drug development and manufacturing facilities to strengthen domestic supply chains and support growing patient demand. The United States led the market growth, supported by strong research and development activities and the presence of major pharmaceutical and eye-care product manufacturers. In June 2025, Bausch + Lomb launched Blink Nourish and Blink Boost preservative-free lubricating eye drops in the U.S. Designed to hydrate the ocular surface and support tear-film stability, these products expand the company's dry-eye portfolio and strengthen competition in the global artificial tears market.

 

Asia Pacific is anticipated to generate the highest demand during the forecast period in the artificial tears market. The region's market growth is driven by the rising prevalence of dry eye syndrome, increasing screen time, and expanding healthcare expenditure in countries such as China and India. The regional market is further propelled by large-scale investments in ophthalmic healthcare facilities and increasing availability of over-the-counter eye care products. In January 2025, Santen Pharmaceutical launched preservative-free artificial tears in China for moderate-to-severe dry eye. Market insights highlight AI-based platforms like TearID in Japan, reflecting innovation trends in the global artificial tears market.

 

 

Top 10 trends in the Artificial Tears Market

1. Shift Toward Preservative-Free Formulations
2. Increased Prevalence of Dry Eye Syndrome (DES)
3. Rise of Long-Lasting Gel-Based Drops
4. Growth of Online Pharmacies and E-commerce.
5. Adoption of Specialized Formulations for Contact Lens Wearers
6. Demand for Biomimetic and Advanced Lubricants
7. Combination Therapies for Complex Eye Conditions
8. Increased Usage of Single-Use Vials
9. Rising Post-LASIK Eye Care
10. Growth in Asia-Pacific and Emerging Markets

 

1. Transition to Preservative-Free Formulations:

Consumers and physicians are adopting preservative-free single-dose units or sophisticated multi-dose bottles to reduce the toxicity and irritation linked to long-term preservative use (such as benzalkonium chloride). Because of the strong demand, this market is anticipated to keep expanding.

 

2. Increased Prevalence of Dry Eye Syndrome (DES):

The main reason propelling market expansion is the rising prevalence of DES brought on by environmental factors, prolonged screen time, and pollution. Globally, DES has become much more common.

 

3. Growth of Long-Lasting Gel-Based Drops:

Compared to conventional liquid eye drops, gel-based and viscous formulations that offer prolonged hydration are highly preferred and require fewer applications.

 

4. Growth of internet Pharmacies and E-commerce:

Due to the ease of buying OTC (over-the-counter) goods at home, internet pharmacies are experiencing a larger compound annual growth rate (CAGR) than other distribution channels.

 

5. Adoption of Customized Formulations for People Who Wear Contact Lenses:

As contact lens use rises, products made specifically for contact lens wearers made to be compatible with lens materials and solve dryness issues—are becoming incredibly popular.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the temporary power market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Artificial Tears Market.

 

Top 20 Companies Leading the Artificial Tears Market

1. Alcon
2. Allergan (AbbVie)
3. Bausch + Lomb
4. Johnson & Johnson Vision Care
5. Santen Pharmaceutical
6. Novartis
7. Sun Pharmaceutical Industries
8. Rohto Pharmaceutical
9. Otsuka Pharmaceutical
10. URSAPHARM Arzneimittel
11. Thea Pharma
12. Medicom Healthcare
13. Similasan Corporation
14. AFT Pharmaceuticals
15. Akorn Operating Company
16. OASIS Medical
17. Eyevance Pharmaceuticals
18. Bayer AG
19. Nicox,
20. Viatris

 

 

1. Alcon

Headquarter: Geneva, Switzerland

Alcon Inc. is a Swiss multinational medical device company founded in 1945. The company specializes in eye care products and surgical solutions for ophthalmology. It provides a wide range of offerings including contact lenses, lens care products, ophthalmic pharmaceuticals, and advanced surgical equipment used in cataract, refractive, and vitreoretinal procedures. Alcon operates globally with over 25,000 employees and recorded revenue of around USD 10 Billion in 2025.

 

2. Allergan (AbbVie)

Headquarter: Irvine, California, United States

Allergan (an AbbVie company) is a global pharmaceutical company originally founded in 1950 and acquired by AbbVie in 2020. The company specializes in developing and manufacturing branded pharmaceuticals, biologics, and medical aesthetic products. Its portfolio includes treatments in medical aesthetics, eye care, neuroscience, gastroenterology, and dermatology, serving healthcare providers and patients worldwide. Allergan operates globally with thousands of employees and contributes significantly to AbbVie’s pharmaceutical portfolio, with combined revenues exceeding USD 50 Billion in 2025.

 

3. Bausch + Lomb

Headquarter: Vaughan, Ontario, Canada

Bausch + Lomb Corporation is a global eye health company founded in 1853 by John Jacob Bausch and Henry Lomb. The company specializes in eye care products, including contact lenses, lens care solutions, ophthalmic pharmaceuticals, and surgical devices used in vision correction and eye health treatments. Its portfolio serves healthcare professionals and consumers worldwide across segments such as vision care, pharmaceuticals, and surgical products. Bausch + Lomb operates globally with over 13,000 employees and recorded revenue of around USD 4 Billion in 2025.

 

4. Johnson & Johnson Vision Care

Headquarter: Jacksonville, Florida, United States

Johnson & Johnson Vision Care, Inc. is a global eye health company founded in 1987 and operates as a subsidiary of Johnson & Johnson. The company specializes in vision care products, particularly contact lenses and related eye health solutions. Its portfolio includes daily and reusable contact lenses, lens care products, and digital eye health technologies designed to improve vision and eye comfort. Johnson & Johnson Vision Care serves healthcare professionals and consumers worldwide through advanced vision care solutions. The company operates globally with thousands of employees and contributes significantly to Johnson & Johnson’s medical technology segment, which generated revenues exceeding USD 30 Billion in 2025.

 

5. Santen Pharmaceutical

Headquarter: Osaka, Japan

Santen Pharmaceutical Co., Ltd. is a Japanese multinational pharmaceutical company founded in 1890. The company specializes in ophthalmology-focused pharmaceuticals and medical solutions for eye diseases and vision care. Its product portfolio includes prescription ophthalmic drugs, over-the-counter eye care products, and surgical devices used in the treatment of glaucoma, dry eye, allergies, and other eye disorders. Santen Pharmaceutical operates globally with over 4,000 employees and recorded revenue of around USD 2 Billion in 2025.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Artificial Tears Market.

 

Company Profiles

 

1. Alcon

 

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

 

1. Allergan (AbbVie)
2. Bausch + Lomb
3. Johnson & Johnson Vision Care
4. Santen Pharmaceutical
5. Novartis
6. Sun Pharmaceutical Industries
7. Rohto Pharmaceutical
8. Otsuka Pharmaceutical
9. URSAPHARM Arzneimittel
10. Thea Pharma
11. Medicom Healthcare
12. Similasan Corporation
13. AFT Pharmaceuticals
14. Akorn Operating Company
15. OASIS Medical
16. Eyevance Pharmaceuticals
17. Bayer AG
18. Nicox,
19. Viatris

 

 

Our Reports

https://www.sphericalinsights.com/reports/south-korea-electric-motors-market 
https://www.sphericalinsights.com/reports/type-4-hydrogen-cylinder-market 
https://www.sphericalinsights.com/reports/united-kingdom-airport-systems-market 
https://www.sphericalinsights.com/reports/united-states-home-appliance-market 

 

Conclusion

The global artificial tears market is expected to witness steady growth, expanding from USD 3.02 billion in 2024 to USD 6.73 billion by 2035 at a CAGR of 7.56%. Growth is primarily driven by increasing cases of dry eye syndrome, rising screen time, aging populations, and growing exposure to environmental pollutants. The market is also benefiting from the shift toward preservative-free formulations, single-dose packaging, and advanced biomimetic lubricants that improve eye comfort and safety. North America is projected to grow rapidly due to strong ophthalmic research and high demand for OTC eye-care products, while Asia-Pacific is expected to generate the highest demand owing to expanding healthcare access and digital lifestyles.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Artificial Tears Market.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter